Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis

NCT05331222 is registered in ClinicalTrials.gov with Jantar GmbH as lead sponsor.

NCT NCT05331222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05331222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis
Lead sponsor
Jantar GmbH
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2022
Completion date
March 3, 2023
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinitis, chronic sinus congestion